Home » Topics » Regulatory » Patents

Patents
RSS

Antimigraine agents with reduced liability for side effects developed at MS&D

Feb. 27, 1998

Orally active thrombin inhibitors prepared at C&C

Feb. 27, 1998

Merck describes newly discovered beta3-adrenoceptor agonists

Feb. 26, 1998

Cell adhesion inhibitors from Yoshitomi

Feb. 26, 1998

Agouron discloses new HIV protease inhibitors

Feb. 26, 1998

Muscarinic cholinergic agents from American Home

Feb. 24, 1998

SKB evaluates RF-1 as antibacterial target

Feb. 23, 1998

Pharmacia & Upjohn develops new antiproliferative agents

Feb. 23, 1998

Chloride channel blockers useful for sickle cell anemia

Feb. 23, 1998

Novel NK1 antagonists described by Merck & Co.

Feb. 23, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...